Maha M. Abdel‐Fattah

1.2k total citations
58 papers, 902 citations indexed

About

Maha M. Abdel‐Fattah is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Maha M. Abdel‐Fattah has authored 58 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Organic Chemistry and 10 papers in Pharmacology. Recurrent topics in Maha M. Abdel‐Fattah's work include Synthesis and biological activity (13 papers), Computational Drug Discovery Methods (6 papers) and Inflammatory mediators and NSAID effects (6 papers). Maha M. Abdel‐Fattah is often cited by papers focused on Synthesis and biological activity (13 papers), Computational Drug Discovery Methods (6 papers) and Inflammatory mediators and NSAID effects (6 papers). Maha M. Abdel‐Fattah collaborates with scholars based in Egypt, Saudi Arabia and India. Maha M. Abdel‐Fattah's co-authors include Ahmed A. Al‐Karmalawy, Ayman Abo Elmaaty, Rasha A. Hassan, Muhammad Khattab, Wafaa R. Mohamed, Khaled M. Darwish, Asmaa E. Kassab, Ahmed S. Doghish, Ehab M. Gedawy and Basim Anwar Shehata Messiha and has published in prestigious journals such as Molecules, International Journal of Pharmaceutics and Life Sciences.

In The Last Decade

Maha M. Abdel‐Fattah

53 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maha M. Abdel‐Fattah Egypt 19 314 271 125 106 72 58 902
Lekshmi R. Nath India 18 353 1.1× 125 0.5× 76 0.6× 117 1.1× 86 1.2× 65 986
Hamadeh Tarazi United Arab Emirates 17 338 1.1× 287 1.1× 97 0.8× 131 1.2× 39 0.5× 37 769
Morteza Ghandadi Iran 14 332 1.1× 189 0.7× 36 0.3× 74 0.7× 66 0.9× 30 763
Thikryat Neamatallah Saudi Arabia 18 301 1.0× 200 0.7× 40 0.3× 73 0.7× 42 0.6× 41 865
Chunping Wan China 16 282 0.9× 188 0.7× 36 0.3× 112 1.1× 91 1.3× 53 756
Georgiana Nițulescu Romania 13 376 1.2× 100 0.4× 51 0.4× 78 0.7× 48 0.7× 28 819
Taha F. S. Ali Egypt 19 286 0.9× 391 1.4× 58 0.5× 77 0.7× 39 0.5× 57 859
Vinay Kumar India 20 379 1.2× 193 0.7× 384 3.1× 155 1.5× 45 0.6× 57 1.0k
Wafa Ali Eltayb Sudan 14 328 1.0× 127 0.5× 135 1.1× 95 0.9× 151 2.1× 40 854
Temitope Isaac Adelusi Nigeria 16 427 1.4× 166 0.6× 218 1.7× 66 0.6× 57 0.8× 45 851

Countries citing papers authored by Maha M. Abdel‐Fattah

Since Specialization
Citations

This map shows the geographic impact of Maha M. Abdel‐Fattah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha M. Abdel‐Fattah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha M. Abdel‐Fattah more than expected).

Fields of papers citing papers by Maha M. Abdel‐Fattah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maha M. Abdel‐Fattah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha M. Abdel‐Fattah. The network helps show where Maha M. Abdel‐Fattah may publish in the future.

Co-authorship network of co-authors of Maha M. Abdel‐Fattah

This figure shows the co-authorship network connecting the top 25 collaborators of Maha M. Abdel‐Fattah. A scholar is included among the top collaborators of Maha M. Abdel‐Fattah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maha M. Abdel‐Fattah. Maha M. Abdel‐Fattah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zanaty, Ali, et al.. (2025). Characterization, genomic analysis and preclinical evaluation of the lytic Staphylococcus bacteriophage PSK against methicillin-resistant Staphylococcus aureus wound isolate. Annals of Clinical Microbiology and Antimicrobials. 24(1). 17–17. 1 indexed citations
2.
Alsaleem, Mansour, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.. (2025). Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery. Journal of Cellular and Molecular Medicine. 29(5). e70378–e70378. 2 indexed citations
3.
Abdelmonem, Rehab, et al.. (2025). Topical loratadine-loaded invasomal gel repurposed for vulvovaginal candidiasis; in vitro, in silico, ex vivo, and in vivo studies. International Journal of Pharmaceutics. 677. 125639–125639. 1 indexed citations
4.
Albash, Rofida, et al.. (2025). Harnessing natural terpenes via PEGylated mucoadhesive vesicles for improved urinary bladder delivery: from in vitro evaluation to in vivo assessment. Frontiers in Pharmacology. 16. 1685423–1685423. 1 indexed citations
5.
Al‐kuraishy, Hayder M., Ali I. Al‐Gareeb, Maha M. Abdel‐Fattah, et al.. (2025). Trajectory of Cardiogenic Dementia: A New Perspective. Journal of Cellular and Molecular Medicine. 29(2). e70345–e70345. 8 indexed citations
6.
Al‐Gareeb, Ali I., Maha M. Abdel‐Fattah, Ahad Amer Alsaiari, et al.. (2025). Targeting of PP2 A/GSK3β/PTEN Axis in Alzheimer Disease: The Mooting Evidence, Divine, and Devil. Cellular and Molecular Neurobiology. 45(1). 36–36. 3 indexed citations
7.
8.
Hassan, Rasha A., Zeinab Mahmoud, Ayman Abo Elmaaty, et al.. (2025). Design, synthesis, and anticancer evaluation of new Quinazoline hybrids: DNA intercalation, topoisomerase IIα inhibition, and in silico studies. Bioorganic Chemistry. 164. 108921–108921.
9.
El-Nabarawi, Mohamed A., Mariam Hassan, Maha M. Abdel‐Fattah, et al.. (2025). PEG-decorated emulsomal gel loaded levocetirizine dihydrochloride as repurposed cure for effective management of methicillin-resistant Staphylococcus aureus (MRSA) vaginal infection: D-optimal design optimization, ex-vivo, in-silico, and in-vivo studies. Journal of Drug Delivery Science and Technology. 115. 107680–107680. 1 indexed citations
10.
Abdel‐Fattah, Maha M., et al.. (2024). A unique implementation of Hantzsch reaction for determination of natamycin in Yoghurt: Hyphenated with Box-Behnken-design for optimization. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 317. 124395–124395. 2 indexed citations
11.
Abdel‐Fattah, Maha M., et al.. (2024). The protective effect of pregabalin and xanthenone on testicular ischemia/reperfusion injury in rats. Fundamental and Clinical Pharmacology. 38(6). 1080–1093.
12.
Abdel‐Fattah, Maha M., et al.. (2023). Probenecid ameliorates testosterone‐induced benign prostatic hyperplasia: Implications of PGE‐2 on ADAM‐17/EGFR/ERK1/2 signaling cascade. Journal of Biochemical and Molecular Toxicology. 37(11). e23450–e23450. 3 indexed citations
13.
Abdel‐Fattah, Maha M., et al.. (2023). Review on EGFR-ERK1/2 signaling cascade: implications on cell proliferation in health and disease. Egyptian Pharmaceutical Journal. 22(4). 535–544. 3 indexed citations
14.
Abdel‐Fattah, Maha M., Emad H. M. Hassanein, Ahmed M. Sayed, et al.. (2023). Targeting SIRT1/FoxO3a/Nrf2 and PI3K/AKT Pathways with Rebamipide Attenuates Acetic Acid-Induced Colitis in Rats. Pharmaceuticals. 16(4). 533–533. 15 indexed citations
15.
16.
Hassan, Rasha A., et al.. (2023). Coumarin derivatives with potential anticancer and antibacterial activity: Design, synthesis, VEGFR‐2 and DNA gyrase inhibition, and in silico studies. Drug Development Research. 84(3). 475–499. 22 indexed citations
17.
Abdel‐Fattah, Maha M., et al.. (2022). Cyclooxygenase-2 activates EGFR–ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology. 31(1). 499–516. 13 indexed citations
18.
Elmaaty, Ayman Abo, Khaled M. Darwish, Muhammad Khattab, et al.. (2021). In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins. Journal of Biomolecular Structure and Dynamics. 40(19). 8866–8893. 62 indexed citations
19.
Hassan, Ghaneya S., et al.. (2016). DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NEW SUCCINIMIDE, 2-IMINOTHIAZOLINE AND OXAZINE DERIVATIVES BASED BENZOPYRONE AS ANTICONVULSANT AGENTS. International Journal of Pharmacy and Pharmaceutical Sciences. 8(4). 222–228. 8 indexed citations
20.
Zahran, H. H., et al.. (2012). Diversity and Environmental Stress Responses of Rhizobial Bacteria from Egyptian Grain Legumes. AUSTRALIAN JOURNAL OF BASIC AND APPLIED SCIENCES. 6(10). 571–583. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lekshmi R. Nath Breakdown of academic impact, for papers by Hamadeh Tarazi Breakdown of academic impact, for papers by Morteza Ghandadi Breakdown of academic impact, for papers by Thikryat Neamatallah Breakdown of academic impact, for papers by Chunping Wan Breakdown of academic impact, for papers by Georgiana Nițulescu Breakdown of academic impact, for papers by Taha F. S. Ali Breakdown of academic impact, for papers by Vinay Kumar Breakdown of academic impact, for papers by Wafa Ali Eltayb Breakdown of academic impact, for papers by Temitope Isaac Adelusi
Rankless by CCL
2026